Delphia (USA)’s BlueLinx BXC Stock Holding History

Delphia (USA)’s Portfolio BXC Stock Details BXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,368	Closed	-$271K	–	295
2022 Q3	$271K	Sell	4,368 -2,925	-40%	-$211K	0.31%	134
2022 Q2	$487K	Buy	+7,293	New	+$548K	0.34%	91
2022 Q1	–	Sell	-2,174	Closed	-$208K	–	333
2021 Q4	$208K	Buy	+2,174	New	+$147K	0.22%	213

Other funds holding BXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

JCP

JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Delphia (USA)'s BXC Position: Q4 2022 in Review

Delphia (USA) sold out of BlueLinx (BXC) in Q4 2022, closing a stake of 4,368 shares — an estimated $271K sold.

Delphia (USA) first reported a position in BXC in Q4 2021 and held it in 3 quarters. The position peaked at $487K in Q2 2022. 145 funds tracked by Wall St. Rank hold BXC as of Q4 2022.

Delphia (USA) reported no remaining BlueLinx position as of Q4 2022 after selling out during the quarter.
Delphia (USA) sold 4,368 BlueLinx shares in Q4 2022, an estimated $271K.
Delphia (USA) first reported a position in BlueLinx in Q4 2021 and held it in 3 quarters.
Delphia (USA)'s BlueLinx position peaked at $487K in Q2 2022.
145 funds tracked by Wall St. Rank held BlueLinx as of Q4 2022.

Based on Delphia (USA)'s 13F filing for Q4 2022, filed 14 Feb 2023.